News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Renovorx and Imugene to Collaborate on Oncolytic Virus Therapy Delivery via Proprietary Trans-arterial Micro-perfusion (TAMP™) Platform
Friday, July 21, 2023RenovoRx Inc Nasdaq RNXT and Imugene Ltd ASX IMU have recently entered into a strategic research collaboration aimed at optimizing the delivery of Imugenes oncolytic virus therapy using RenovoRxs TAMP TransArterial MicroPerfusion therapy platform
Grifols Announces Positive Topline Results From Phase 4 Study of XEMBIFY® (Immune Globulin Subcutaneous Human-klhw) Evaluating Biweekly Dosing Option for Patients
Friday, July 21, 2023Grifols a leading producer of plasmaderived medicines has announced positive results from a phase trial NCT evaluating the use of XEMBIFY in patients with primary immunodeficiencies PIDs
Mindbio Therapeutics Initiates Pre-screening of Participants for Groundbreaking Phase 2 Trial: Evaluating Home-based Lsd-microdosing in Major Depressive Disorder Patients
Thursday, July 20, 2023MindBio Therapeutics Corp CSEMBIOFrankfurtWF has recently initiated the prescreening process for participants in Phase LSDMicrodosing clinical trials signifying a significant step forward for the company
NANOBIOTIX Commences Novel Phase 1/2 Study to Assess Radiotherapy-activated NBTXR3 Alongside Anti-PD-1 Therapy in Advanced Cancer Patients
Thursday, July 20, 2023Nanobiotix a latestage biotechnology company focused on advancing cancer treatments through physicsbased approaches has announced the initiation of a Phase study to evaluate their product NBTXR in combination with antiPDL immune checkpoint inhibitor...
QIAGEN expands its offerings of digital PCR kits and services for the biopharma industry
Wednesday, July 19, 2023QIAGEN a leading biotechnology company listed on NYSE and Frankfurt Prime Standard has recently expanded its digital PCR dPCR offerings for the biopharma industrys cell and gene therapy development
Revolo Biotherapeutics Unveils New Phase 2a Trial Findings of '1104 in Adults With Active Eosinophilic Esophagitis
Wednesday, July 19, 2023Revolo Biotherapeutics has unveiled additional data from its Phase a clinical trial investigating the effectiveness safety and tolerability of their immuneresetting drug in adults with active eosinophilic esophagitis EoE a chronic allergic inflammat...
Grifols Successfully Concludes Phase 3 Enrollment for Long-term Albutein® Therapy in Patients With Decompensated Cirrhosis
Wednesday, July 19, 2023Grifols a renowned producer of plasmaderived medications has successfully concluded the enrollment phase for PRECIOSA NCT a phase clinical trial
LIXTE Biotechnology and the Netherlands Cancer Institute Unveil Novel Mechanism for LB-100, Enhancing Immunotherapy and Chemotherapy Effectiveness in Preclinical Results
Tuesday, July 18, 2023LIXTE Biotechnology Holdings Inc LIXTE or the Company has made a significant breakthrough in cancer research through a fruitful collaboration with the Netherlands Cancer Institute
Clearside Biomedical Commences Enrolling Numerous Participants in ODYSSEY Phase 2b Clinical Trial Assessing CLS-AX (Axitinib Injectable Suspension) for Wet AMD
Tuesday, July 18, 2023Clearside Biomedical Inc Nasdaq CLSD is a biopharmaceutical company focused on revolutionizing the delivery of therapies for eye conditions by utilizing the suprachoroidal space SCS
Adcentrx Therapeutics Receives FDA Clearance for Investigational New Drug Application of ADRX-0706, an Innovative ADC Targeting Nectin-4 to Treat Advanced Solid Tumors
Tuesday, July 18, 2023Adcentrx Therapeutics is a pioneering biotechnology company dedicated to revolutionizing AntibodyDrug Conjugate ADC therapies for cancer and other lifethreatening diseases Recently the US Food and Drug Administration FDA granted clearance to Adcentrx...
